tiprankstipranks
Advertisement
Advertisement

PCRX Stock Latest News

Pacira announces UnitedHealth provides separate reimbursement for Exparel
The FlyPacira announces UnitedHealth provides separate reimbursement for Exparel
9d ago
UNH
PCRX
Pacira Buy Rating Reiterated as Strategic Refocus Supports Unchanged $32 Price Target
PremiumRatings
Pacira Buy Rating Reiterated as Strategic Refocus Supports Unchanged $32 Price Target
10d ago
PCRX
Pacira BioSciences Divests CryoTech to Zimmer Biomet
PremiumCompany Announcements
Pacira BioSciences Divests CryoTech to Zimmer Biomet
10d ago
8K
PCRX
Pacira Zimmer to divest iovera degrees to Biomet for $70M upfront
PremiumThe Fly
Pacira Zimmer to divest iovera degrees to Biomet for $70M upfront
10d ago
ZBH
PCRX
Pacira Pharmaceuticals Shareholders Back ESPP, Refresh Board Committees
PremiumCompany Announcements
Pacira Pharmaceuticals Shareholders Back ESPP, Refresh Board Committees
29d ago
8K
PCRX
Glass Lewis recommends shareholders vote for Pacira director nominees
PremiumThe FlyGlass Lewis recommends shareholders vote for Pacira director nominees
1M ago
PCRX
Pacira study shows Exparel reduces opioid use and costs
Premium
The Fly
Pacira study shows Exparel reduces opioid use and costs
1M ago
PCRX
Pacira issues statement on DOMA’s ‘misleading’ statements
Premium
The Fly
Pacira issues statement on DOMA’s ‘misleading’ statements
2M ago
PCRX
Doma Perpetual urges Pacira shareholders to vote for its board candidates
PremiumThe Fly
Doma Perpetual urges Pacira shareholders to vote for its board candidates
2M ago
PCRX
Doma Perpetual urges Pacira shareholders to vote for its board candidates
PremiumThe Fly
Doma Perpetual urges Pacira shareholders to vote for its board candidates
2M ago
PCRX
Pacira Earnings Call Highlights Growth, Pipeline Momentum
PremiumCompany Announcements
Pacira Earnings Call Highlights Growth, Pipeline Momentum
2M ago
PCRX
Pacira price target raised to $32 from $30 at Needham
PremiumThe Fly
Pacira price target raised to $32 from $30 at Needham
2M ago
PCRX
AI Models Turn More Positive on Pacira Pharmaceuticals as Cash Flow and Balance Sheet Strength Offset Valuation Concerns
PremiumAI Analyst RatingsAI Models Turn More Positive on Pacira Pharmaceuticals as Cash Flow and Balance Sheet Strength Offset Valuation Concerns
2M ago
PCRX
Pacira reports Q1 EPS 60c, consensus 56c
Premium
The Fly
Pacira reports Q1 EPS 60c, consensus 56c
2M ago
PCRX
Pacira backs FY26 revenue view $745M-$770M, consensus $760.65M
Premium
The Fly
Pacira backs FY26 revenue view $745M-$770M, consensus $760.65M
2M ago
PCRX
PCRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
PCRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
PCRX
Exparel’s Proven Clinical and Economic Value Underpins Buy Rating and $38 Price Target on Pacira BioSciences
PremiumRatings
Exparel’s Proven Clinical and Economic Value Underpins Buy Rating and $38 Price Target on Pacira BioSciences
3M ago
PCRX
Pacira real-world data clearer in hip arthroplasty, says H.C. Wainwright
PremiumThe Fly
Pacira real-world data clearer in hip arthroplasty, says H.C. Wainwright
3M ago
PCRX
Pacira presents data showing lower healthcare costs for Exparel
PremiumThe Fly
Pacira presents data showing lower healthcare costs for Exparel
3M ago
PCRX
Pacira price target lowered to $25 from $27 at Barclays
PremiumThe FlyPacira price target lowered to $25 from $27 at Barclays
4M ago
PCRX
Doma Perpetual nominates three to Pacira board
Premium
The Fly
Doma Perpetual nominates three to Pacira board
4M ago
PCRX
Pacira reports inducement grants under Nasdaq listing rule
Premium
The Fly
Pacira reports inducement grants under Nasdaq listing rule
4M ago
PCRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >